PROSTATE CANCER CLASSIFICATION

A method is provided for characterising and/or prognosing prostate cancer in a subject comprising determining the expression level of at least one of CREM, ERRFI1, SRSF5, PDK4, HJURP, PDRG1, TRPM3, PDE4D, F12, ADAMTS1, ADAMTS9, B3GNT5, CD38, CEBPD, CENPF, DKK1, EMP1, F3, IL1 R1, IL8, JUNB, KLF10, KL...

Full description

Saved in:
Bibliographic Details
Main Authors Laura HILL, Andrena MCCAVIGAN, Timothy DAVISON, Paul HARKIN, Steven WALKER, Richard KENNEDY
Format Patent
LanguageEnglish
Spanish
Published 13.10.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A method is provided for characterising and/or prognosing prostate cancer in a subject comprising determining the expression level of at least one of CREM, ERRFI1, SRSF5, PDK4, HJURP, PDRG1, TRPM3, PDE4D, F12, ADAMTS1, ADAMTS9, B3GNT5, CD38, CEBPD, CENPF, DKK1, EMP1, F3, IL1 R1, IL8, JUNB, KLF10, KLF4, LDLR, LGALS3, LPAR1, MALAT1, MTUS1, MYBPC1, NFIL3, NR4A3, OAT, PI15, PTGS2, RHOBTB3, RIN2, RNFT2, SELE, SLC15A2, SOCS2, SOCS3, SSTR1, ST6GAL1, TSC22D1, XBP1 and ZFP36 in a sample from the subject. The method may be used to predict the likelihood of metastasis. Also disclosed are methods for diagnosing and selecting treatment for prostate cancer, together with corresponding methods of treatment. Systems, kits and computer programs for performing the methods are also provided. Se proporciona un método para la caracterización y/o pronóstico de cáncer de próstata en un individuo, que consiste en: determinar el nivel de expresión de al menos uno de los siguientes CREM, ERRFI1, SRSF5, PDK4, HJURP, PDRG1, TRPM3, PDE4D, F12, ADAMTS1, ADAMTS9, B3GNT5, CD38, CEBPD, CENPF, DKK1, EMP1, F3, IL1 R1, IL8, JUNB, KLF10, KLF4, LDLR, LGALS3, LPAR1, MALAT1, MTUS1, MYBPC1, NFIL3, NR4A3, OAT, PI15, PTGS2, RHOBTB3, RIN2, RNFT2, SELE, SLC15A2, SOCS2, SOCS3, SSTR1, ST6GAL1, TSC22D1, XBP1 y ZFP36 en una muestra obtenida del individuo. El método puede utilizarse para predecir la probabilidad de metástasis. También se describen los métodos para el diagnóstico y selección del tratamiento para cáncer de próstata, junto con los métodos de tratamiento correspondientes. También se proporcionan sistemas, kits y programas de cómputo para realizar los métodos.
AbstractList A method is provided for characterising and/or prognosing prostate cancer in a subject comprising determining the expression level of at least one of CREM, ERRFI1, SRSF5, PDK4, HJURP, PDRG1, TRPM3, PDE4D, F12, ADAMTS1, ADAMTS9, B3GNT5, CD38, CEBPD, CENPF, DKK1, EMP1, F3, IL1 R1, IL8, JUNB, KLF10, KLF4, LDLR, LGALS3, LPAR1, MALAT1, MTUS1, MYBPC1, NFIL3, NR4A3, OAT, PI15, PTGS2, RHOBTB3, RIN2, RNFT2, SELE, SLC15A2, SOCS2, SOCS3, SSTR1, ST6GAL1, TSC22D1, XBP1 and ZFP36 in a sample from the subject. The method may be used to predict the likelihood of metastasis. Also disclosed are methods for diagnosing and selecting treatment for prostate cancer, together with corresponding methods of treatment. Systems, kits and computer programs for performing the methods are also provided. Se proporciona un método para la caracterización y/o pronóstico de cáncer de próstata en un individuo, que consiste en: determinar el nivel de expresión de al menos uno de los siguientes CREM, ERRFI1, SRSF5, PDK4, HJURP, PDRG1, TRPM3, PDE4D, F12, ADAMTS1, ADAMTS9, B3GNT5, CD38, CEBPD, CENPF, DKK1, EMP1, F3, IL1 R1, IL8, JUNB, KLF10, KLF4, LDLR, LGALS3, LPAR1, MALAT1, MTUS1, MYBPC1, NFIL3, NR4A3, OAT, PI15, PTGS2, RHOBTB3, RIN2, RNFT2, SELE, SLC15A2, SOCS2, SOCS3, SSTR1, ST6GAL1, TSC22D1, XBP1 y ZFP36 en una muestra obtenida del individuo. El método puede utilizarse para predecir la probabilidad de metástasis. También se describen los métodos para el diagnóstico y selección del tratamiento para cáncer de próstata, junto con los métodos de tratamiento correspondientes. También se proporcionan sistemas, kits y programas de cómputo para realizar los métodos.
Author Richard KENNEDY
Laura HILL
Andrena MCCAVIGAN
Timothy DAVISON
Steven WALKER
Paul HARKIN
Author_xml – fullname: Laura HILL
– fullname: Andrena MCCAVIGAN
– fullname: Timothy DAVISON
– fullname: Paul HARKIN
– fullname: Steven WALKER
– fullname: Richard KENNEDY
BookMark eNrjYmDJy89L5WSQCwjyDw5xDHFVcHb0c3YNUnD2cQwO9nTzdHYM8fT342FgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8b4RRgaGZgYG5sbGxo7GRCkCANtdI6k
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
DocumentTitleAlternate CLASIFICACION DE CANCER DE PROSTATA.
ExternalDocumentID MX2016007333A
GroupedDBID EVB
ID FETCH-epo_espacenet_MX2016007333A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:54:28 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_MX2016007333A3
Notes Application Number: MX20160007333
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161013&DB=EPODOC&CC=MX&NR=2016007333A
ParticipantIDs epo_espacenet_MX2016007333A
PublicationCentury 2000
PublicationDate 20161013
PublicationDateYYYYMMDD 2016-10-13
PublicationDate_xml – month: 10
  year: 2016
  text: 20161013
  day: 13
PublicationDecade 2010
PublicationYear 2016
RelatedCompanies ALMAC DIAGNOSTICS LIMITED
RelatedCompanies_xml – name: ALMAC DIAGNOSTICS LIMITED
Score 2.9192145
Snippet A method is provided for characterising and/or prognosing prostate cancer in a subject comprising determining the expression level of at least one of CREM,...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PHYSICS
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
TESTING
VINEGAR
WINE
Title PROSTATE CANCER CLASSIFICATION
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161013&DB=EPODOC&locale=&CC=MX&NR=2016007333A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LSsNAcKhVqzeNilotQSS3YMLmeQiSbhKKmCbEKLmVJtlAEbSYiL_v7JJqTz3uzjL7gHnuPADuG8chaDVYKrN4UW3NdlWn1FzVRmZYMbKsLcb9kPHcmr0aT4VZDOB9kwsj6oT-iOKISFEV0nsn-PX634kViNjK9qFc4dTnY5R7gdJbx6i-oEqjBFMvTJMgoQqlXlwo80zARINC4u_BPurRNieH8G3K01LW2zIlOoGDFNF9dKcwYK0ER3TTek2CUdz_eEtwKEI0K1ww6smwPYNJmiUvuZ-HMuW9ZTKZPvvIFaM-K_gc7qIwpzMVt1z8XXARF1vHIxcwRMufXYJsOszWWcNr9DXG0nJKU6_10iaNa6Dg0eorGO9AdL0TOoZjPuJsWCc3MOy-vtktyteunIh3-QWoYHkY
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ7Uqq03RY1arY0x3IgQyutADF0gqOURRMONFLokxkQbwfj3nd1Q7anXnc3sI_nmsTsPgNvaNFX0GnSJ6qyotmxYklnKlmSgMKyouljqlL1DhpEevEwfcy3vwfs6F4bXCf3hxRERURXiveXyevX_iOXy2MrmrnzDoc97P7NdsfOO0XxBk0Z0Z7aXxG5MRELsMBejlNN4g0LV2YFdtLENBgfvdcbSUlabOsU_hL0E2X20R9CjjQBDsm69JsAg7H68BdjnIZoVThh0MGyOYZyk8XPmZN6EsN4y6YTMHZSKfpcVfAI3vpeRQMIli78DFmG-sT31FPro-dMzmGgmNRRasxp99XShm6WmLJXSUGtriopHXp7DaAuji63UaxgGWTgv5g_R0wgOGIWJZEW9hH779U2vUNe25Zjf0S-BWHwL
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PROSTATE+CANCER+CLASSIFICATION&rft.inventor=Laura+HILL&rft.inventor=Andrena+MCCAVIGAN&rft.inventor=Timothy+DAVISON&rft.inventor=Paul+HARKIN&rft.inventor=Steven+WALKER&rft.inventor=Richard+KENNEDY&rft.date=2016-10-13&rft.externalDBID=A&rft.externalDocID=MX2016007333A